Ligand Pharmaceuticals, Inc. (LGND)

189.94 +2.43 (+1.30%) USD  |  NASDAQ  |  Feb 18, 16:00
190.12 +0.18 (+0.09%) Pre-Market: 20:00
More

Ligand Pharmaceuticals Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Johnson & Johnson Upgrade
Elanco Animal Health, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade